Change Impact of Body Composition During Neoadjuvant Chemoradiotherapy in Patients with Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma Undergoing Pancreatectomy

被引：0
|
作者：
Shohei Takaichi
Yoshito Tomimaru
Shogo Kobayashi
Keisuke Toya
Kazuki Sasaki
Yoshifumi Iwagami
Daisaku Yamada
Takehiro Noda
Hidenori Takahashi
Tadafumi Asaoka
Masahiro Tanemura
Yuichiro Doki
Hidetoshi Eguchi
机构：
[1] Osaka University Graduate School of Medicine,Department of Gastroenterological Surgery
[2] Osaka Police Hospital,Department of Surgery
[3] Rinku General Medical Center,Department of Surgery
来源：
Annals of Surgical Oncology | 2023年 / 30卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2458 / 2468
页数：10
相关论文
共 50 条
  • [21] Prognostic Factors in Patients With Borderline Resectable Pancreatic Ductal Adenocarcinoma Undergoing Resection
    Ren, Weizheng
    Xourafas, Dimitrios
    Ashley, Stanley W.
    Clancy, Thomas E.
    AMERICAN SURGEON, 2022, 88 (06) : 1172 - 1180
  • [22] Updates on adjuvant and neoadjuvant treatment strategies for surgically resectable and borderline resectable pancreatic ductal adenocarcinoma
    Iyengar, Siddharth
    Nevala-Plagemann, Christopher
    Garrido-Laguna, Ignacio
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2021, 13
  • [23] Neoadjuvant Phase II Trial of Chemoradiotherapy in Patients With Resectable and Borderline Resectable Pancreatic Cancer
    Thanikachalam, Kannan
    Damarla, Vijay
    Seixas, Trevor
    Dobrosotskaya, Irina
    Wollner, Ira
    Kwon, David
    Winters, Kenneth
    Raoufi, Mohammad
    Li, Jia
    Siddiqui, Farzan
    Khan, Gazala
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2020, 43 (06): : 435 - 441
  • [24] Neoadjuvant Treatment for Resectable and Borderline Resectable Pancreatic Cancer: Chemotherapy or Chemoradiotherapy?
    Versteijne, Eva
    de Hingh, Ignace H. J. T.
    Homs, Marjolein Y. V.
    Intven, Martijn P. W.
    Klaase, Joost M.
    van Santvoort, Hjalmar C.
    de Vos-Geelen, Judith
    Wilmink, Johanna W.
    van Tienhoven, Geertjan
    FRONTIERS IN ONCOLOGY, 2022, 11
  • [25] Assessment of Response to Neoadjuvant Therapy Using CT Texture Analysis in Patients With Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma
    Borhani, Amir A.
    Dewan, Rohit
    Furlan, Alessandro
    Seiser, Natalie
    Zureikat, Amer H.
    Singhi, Aatur D.
    Boone, Brian
    Bahary, Nathan
    Hogg, Melissa E.
    Lotze, Michael
    Zeh, Herbert J., III
    Tublin, Mitchell E.
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2020, 214 (02) : 362 - 369
  • [26] Optimal Treatment for Octogenarians With Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma
    Satoi, S.
    Yamamoto, T.
    Uchida, K.
    Fujii, T.
    Kin, T.
    Asano, T.
    Hanada, K.
    Itoi, T.
    Murakami, Y.
    Igarashi, H.
    Eguchi, H.
    Kuroki, T.
    Shimizu, Y.
    Tani, M.
    Tanno, S.
    Tsuji, Y.
    Hirooka, Y.
    Masamune, A.
    Mizumoto, K.
    Shimokawa, T.
    Yamaue, H.
    Okazaki, K.
    PANCREAS, 2019, 48 (10) : 1516 - 1517
  • [27] Long-term survival of patients receiving multimodality neoadjuvant therapy for resectable or borderline resectable pancreatic ductal adenocarcinoma
    McCormick, Kinsey
    Whiting, Samuel H.
    Gyurkey, Grace
    Koh, Wui-Jin
    Sinanan, Mika
    Coveler, Andrew L.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (03)
  • [28] Neoadjuvant fractionated versus hypofractionated chemoradiotherapy in resectable and borderline resectable pancreatic cancer
    Lee, Darren
    Nelson, Bailey
    Rai, Shesh
    Rai, Jayesh
    Wang, Kyle
    Sohal, Davendra
    Olowokure, Olugbenga Olanrele
    Rojan, Adam
    Patel, Sameer H.
    Wilson, Gregory
    Ahmad, Syed A.
    Kharofa, Jordan
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [29] Borderline resectable pancreatic cancer and the role of neoadjuvant chemoradiotherapy
    di Sebastiano, Pierluigi
    Grottola, Tommaso
    di Mola, F. Francesco
    UPDATES IN SURGERY, 2016, 68 (03) : 235 - 239
  • [30] Neoadjuvant Gemcitabine-based Accelerated Hyperfractionation Chemoradiotherapy for Patients with Borderline Resectable Pancreatic Adenocarcinoma
    Takeda, Yutaka
    Nakamori, Shoji
    Eguchi, Hidetoshi
    Kobayashi, Shogo
    Marubashi, Shigeru
    Tanemura, Masahiro
    Konishi, Koji
    Yoshioka, Yasuo
    Umeshita, Koji
    Mori, Masaki
    Doki, Yuichiro
    Nagano, Hiroaki
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2014, 44 (12) : 1172 - 1180
12345